SHR-1210 Combined With Local Treatment in NSCLC Patients With BM
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Brain Metastases
- Immunotherapy
- NSCLC Stage IV
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
To evaluate the efficacy and safety of SHR-1210 combined with local treatment of brain metastases (WBRT, r-knife, SRS, etc.) in non-small cell lung cancer with brain metastases .
To evaluate the efficacy and safety of SHR-1210 combined with local treatment of brain metastases (WBRT, r-knife, SRS, etc.) in non-small cell lung cancer with brain metastases .
Tracking Information
- NCT #
- NCT04291092
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon